Skip to main content
SpringerLink
Log in

Alirocumab/evolocumab

Injection site reactions: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Singh SK, et al. Are Injection Site Reactions in Monoclonal Antibody Therapies Caused by Polysorbate Excipient Degradants?. Journal of Pharmaceutical Sciences 107: 2735-2741, No. 11, Nov 2018. Available from: URL: http://doi.org/10.1016/j.xphs.2018.07.016 - Switzerland

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alirocumab/evolocumab. Reactions Weekly 1728, 22 (2018). https://doi.org/10.1007/s40278-018-54285-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-54285-1

Search

Navigation